Apellis Pharmaceuticals (NASDAQ:APLS) Trading Up 5.1% on Analyst Upgrade
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Get Free Report) was up 5.1% during trading on Friday after Wedbush raised their price target on the stock from $39.00 to $60.00. Wedbush currently has a neutral rating on the stock. Apellis Pharmaceuticals traded as high as $69.66 and last traded at $69.46. Approximately 966,493 shares traded hands during […]
More Stories
Sysco Co. (NYSE:SYY) Shares Purchased by Leelyn Smith LLC
Leelyn Smith LLC boosted its stake in Sysco Co. (NYSE:SYY – Free Report) by 5.0% in the 3rd quarter, according...
Stonebrook Private Inc. Lowers Position in Johnson & Johnson (NYSE:JNJ)
Stonebrook Private Inc. trimmed its stake in Johnson & Johnson (NYSE:JNJ – Free Report) by 0.5% during the 3rd quarter,...
49 Wealth Management LLC Grows Stock Position in Pfizer Inc. (NYSE:PFE)
49 Wealth Management LLC increased its position in Pfizer Inc. (NYSE:PFE – Free Report) by 7.4% in the 3rd quarter,...
Pitcairn Co. Has $2.91 Million Stock Holdings in NextEra Energy, Inc. (NYSE:NEE)
Pitcairn Co. cut its position in shares of NextEra Energy, Inc. (NYSE:NEE – Free Report) by 3.2% during the third...
Meridian Wealth Management LLC Makes New $1.65 Million Investment in The Walt Disney Company (NYSE:DIS)
Meridian Wealth Management LLC acquired a new position in shares of The Walt Disney Company (NYSE:DIS – Free Report) during...
NextEra Energy, Inc. (NYSE:NEE) Shares Sold by Hamilton Point Investment Advisors LLC
Hamilton Point Investment Advisors LLC trimmed its holdings in NextEra Energy, Inc. (NYSE:NEE – Free Report) by 0.6% in the...